Randomized Phase II Study of Neoadjuvant Checkpoint Blockade for Surgically Resectable Undifferentiated Pleomorphic Sarcoma (UPS) and Dedifferentiated Liposarcoma (DDLPS): Survival Results after 2 Years of Follow-Up and Intratumoral B-cell Receptor (BCR) Correlates.
JOURNAL OF CLINICAL ONCOLOGY(2022)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要